FFBW, Inc. (FFBW)

CTI BioPharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	53	62	53	58	75	71
Market Cap Growth	1.68%	16.63%	-8.46%	-21.72%	4.50%	-2.47%
Last Close Price	13.75	14.24	11.99	11.61	11.80	10.02
PE Ratio	25.48	26.04	35.40	24.92	37.59	38.96
PS Ratio	4.34	5.20	4.51	4.73	6.42	7.04
PB Ratio	0.72	0.82	0.72	0.75	0.79	0.69
P/FCF Ratio	-	14.14	16.96	19.53	17.92	40.33
P/OCF Ratio	-	13.71	16.19	12.98	17.07	39.09
Debt / Equity Ratio	-	-	0.01	0.11	0.07	0.07
Debt / FCF Ratio	-	-	0.22	2.97	1.56	4.24
Return on Equity (ROE)	3.27%	3.19%	1.98%	2.72%	2.01%	2.22%
Return on Assets (ROA)	0.78%	0.79%	0.47%	0.69%	0.57%	0.58%
Earnings Yield	4.58%	3.84%	2.83%	4.01%	2.66%	2.57%
FCF Yield	-	7.07%	5.90%	5.12%	5.58%	2.48%
Buyback Yield / Dilution	1.96%	4.43%	14.51%	15.55%	8.07%	9.43%

Source: S&P Global Market Intelligence. Banks template. Financial Sources.